Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evenity
Pharma
Improved access helps Amgen's Tepezza to a sales increase
In the second quarter, Amgen's Tepezza emerged from its stagnation ,generating $479 million in sales for an increase of 8% YOY and 13% sequentially.
Kevin Dunleavy
Aug 7, 2024 8:35am
Amgen reports 3rd straight sequential sales increase for Tepezza
Feb 7, 2024 10:03am
Amgen's Prolia flagged by the FDA for risk of hypocalcemia
Jan 19, 2024 3:35pm
Kansas company sues Amgen for alleged infringement with Evenity
Apr 25, 2023 2:46pm
Bushu and Amgen expand Asian contract manufacturing pact
Nov 24, 2021 11:15am
Amgen's Evenity wins #FierceMadness championship
Apr 13, 2020 10:30am
